Patent Assignment
Reel/Frame 071375/0224
Change of Name
Recorded: 2025-06-10
Pages: 5
Assignor
MARINUS PHARMACEUTICALS, INC.
Executed: 2025-02-25
Assignee
IMMEDICA PHARMA US INC.
150 N. MICHIGAN AVENUE, SUITE 1950, CHICAGO, ILLINOIS, 60601
Covered Properties
(3)
Ganaxolone for Use in Treatment of Status Epilepticus
Ganaxolone for Use in Treatment of Status Epilepticus
Ganaxolone for Use in Treatment of Status Epilepticus
Related Assignments
(7)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Mar 10, 2021
From: CZEKAI, DAVID; GASIOR, MACIEJ; MASUOKA, LORIANNE; TSAI, JULIA
To: MARINUS PHARMACEUTICALS, INC.
Reel/Frame 055555/0867 →
Security Interest
May 11, 2021
From: MARINUS PHARMACEUTICALS, INC.
To: OAKTREE FUND ADMINISTRATION, LLC
Reel/Frame 056206/0266 →
Assignment of Assignor's Interest
Aug 4, 2021
From: CZEKAI, DAVID; GASIOR, MACIEJ; MASUOKA, LORIANNE; TSAI, JULIA
To: MARINUS PHARMACEUTICALS, INC.
Reel/Frame 057078/0006 →
Assignment of Assignor's Interest
Jun 1, 2022
From: CZEKAI, DAVID; GASIOR, MACIEJ; MASUOKA, LORIANNE; TSAI, JULIA
To: MARINUS PHARMACEUTICALS, INC.
Reel/Frame 060067/0634 →
Security Interest
Oct 28, 2022
From: MARINUS PHARMACEUTICALS, INC.
To: SAGARD HEALTHCARE ROYALTY PARTNERS, LP
Reel/Frame 061580/0171 →
Release of Security Interest
Feb 13, 2025
From: SAGARD HEALTHCARE PARTNERS FUNDING COMPANY SPE 1, LLC
To: MARINUS PHARMACEUTICALS, INC.
Reel/Frame 070204/0035 →
Release of Security Interest
Feb 20, 2025
From: OAKTREE FUND ADMINISTRATION, LLC
To: MARINUS PHARMACEUTICALS, INC.
Reel/Frame 070278/0496 →